1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) decreases glutamate uptake in cultured astrocytes

Alan S. Hazell, Yossef Itzhak, Huaping Liu, Michael D Norenberg

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

The deleterious effect of the parkinsonian neurotoxin 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine (MPTP) on dopaminergic neurons of the substantia nigra is well established. In addition, increased glutamatergic drive to basal ganglia output nuclei is considered a likely contributor to the pathogenesis of Parkinson's disease. One possibility for the increased excitatory tone may be related to an impairment in glutamate uptake. As astrocytes possess efficient transport mechanisms for both MPTP and glutamate, we have examined the effect of this agent on D-aspartate uptake into these cells. Treatment of cultures with 50 μM MPTP for 24 h decreased uptake by 39%. Kinetic analysis revealed that this effect was due to a 35% decrease in V(max) with no change in the K(m). Treatment with deprenyl, a monoamine oxidase B inhibitor, produced a complete reversal of MPTP-induced uptake inhibition, but was ineffective following exposure of cells to the MPTP metabolite, 1-methyl-4-phenylpyridinium (MPP+). Removal of MPTP from cultures resulted in a complete restoration of glutamate uptake after 24 h. These results show that MPTP reversibly compromises glutamate uptake in cultured astrocytes, which is dependent on the conversion of MPTP to MPP+. Such findings suggest that the glutamate transporter in astrocytes plays an important role in MPTP-induced neurotoxicity and possibly in parkinsonism.

Original languageEnglish
Pages (from-to)2216-2219
Number of pages4
JournalJournal of Neurochemistry
Volume68
Issue number5
StatePublished - May 1 1997

Fingerprint

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Astrocytes
Glutamic Acid
1-Methyl-4-phenylpyridinium
Selegiline
Amino Acid Transport System X-AG
D-Aspartic Acid
Monoamine Oxidase Inhibitors
Dopaminergic Neurons
Monoamine Oxidase
Neurotoxins
Parkinsonian Disorders
Substantia Nigra
Metabolites
Basal Ganglia
Restoration
Neurons
Parkinson Disease
Kinetics

Keywords

  • 1-Methyl-4-phenyl-l,2,3,6- tetrahydropyridine
  • Astrocytes
  • Glutamate transport
  • Parkinson's disease

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) decreases glutamate uptake in cultured astrocytes. / Hazell, Alan S.; Itzhak, Yossef; Liu, Huaping; Norenberg, Michael D.

In: Journal of Neurochemistry, Vol. 68, No. 5, 01.05.1997, p. 2216-2219.

Research output: Contribution to journalArticle

@article{fab234859e6d45ab888963d36f37d503,
title = "1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) decreases glutamate uptake in cultured astrocytes",
abstract = "The deleterious effect of the parkinsonian neurotoxin 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine (MPTP) on dopaminergic neurons of the substantia nigra is well established. In addition, increased glutamatergic drive to basal ganglia output nuclei is considered a likely contributor to the pathogenesis of Parkinson's disease. One possibility for the increased excitatory tone may be related to an impairment in glutamate uptake. As astrocytes possess efficient transport mechanisms for both MPTP and glutamate, we have examined the effect of this agent on D-aspartate uptake into these cells. Treatment of cultures with 50 μM MPTP for 24 h decreased uptake by 39{\%}. Kinetic analysis revealed that this effect was due to a 35{\%} decrease in V(max) with no change in the K(m). Treatment with deprenyl, a monoamine oxidase B inhibitor, produced a complete reversal of MPTP-induced uptake inhibition, but was ineffective following exposure of cells to the MPTP metabolite, 1-methyl-4-phenylpyridinium (MPP+). Removal of MPTP from cultures resulted in a complete restoration of glutamate uptake after 24 h. These results show that MPTP reversibly compromises glutamate uptake in cultured astrocytes, which is dependent on the conversion of MPTP to MPP+. Such findings suggest that the glutamate transporter in astrocytes plays an important role in MPTP-induced neurotoxicity and possibly in parkinsonism.",
keywords = "1-Methyl-4-phenyl-l,2,3,6- tetrahydropyridine, Astrocytes, Glutamate transport, Parkinson's disease",
author = "Hazell, {Alan S.} and Yossef Itzhak and Huaping Liu and Norenberg, {Michael D}",
year = "1997",
month = "5",
day = "1",
language = "English",
volume = "68",
pages = "2216--2219",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) decreases glutamate uptake in cultured astrocytes

AU - Hazell, Alan S.

AU - Itzhak, Yossef

AU - Liu, Huaping

AU - Norenberg, Michael D

PY - 1997/5/1

Y1 - 1997/5/1

N2 - The deleterious effect of the parkinsonian neurotoxin 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine (MPTP) on dopaminergic neurons of the substantia nigra is well established. In addition, increased glutamatergic drive to basal ganglia output nuclei is considered a likely contributor to the pathogenesis of Parkinson's disease. One possibility for the increased excitatory tone may be related to an impairment in glutamate uptake. As astrocytes possess efficient transport mechanisms for both MPTP and glutamate, we have examined the effect of this agent on D-aspartate uptake into these cells. Treatment of cultures with 50 μM MPTP for 24 h decreased uptake by 39%. Kinetic analysis revealed that this effect was due to a 35% decrease in V(max) with no change in the K(m). Treatment with deprenyl, a monoamine oxidase B inhibitor, produced a complete reversal of MPTP-induced uptake inhibition, but was ineffective following exposure of cells to the MPTP metabolite, 1-methyl-4-phenylpyridinium (MPP+). Removal of MPTP from cultures resulted in a complete restoration of glutamate uptake after 24 h. These results show that MPTP reversibly compromises glutamate uptake in cultured astrocytes, which is dependent on the conversion of MPTP to MPP+. Such findings suggest that the glutamate transporter in astrocytes plays an important role in MPTP-induced neurotoxicity and possibly in parkinsonism.

AB - The deleterious effect of the parkinsonian neurotoxin 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine (MPTP) on dopaminergic neurons of the substantia nigra is well established. In addition, increased glutamatergic drive to basal ganglia output nuclei is considered a likely contributor to the pathogenesis of Parkinson's disease. One possibility for the increased excitatory tone may be related to an impairment in glutamate uptake. As astrocytes possess efficient transport mechanisms for both MPTP and glutamate, we have examined the effect of this agent on D-aspartate uptake into these cells. Treatment of cultures with 50 μM MPTP for 24 h decreased uptake by 39%. Kinetic analysis revealed that this effect was due to a 35% decrease in V(max) with no change in the K(m). Treatment with deprenyl, a monoamine oxidase B inhibitor, produced a complete reversal of MPTP-induced uptake inhibition, but was ineffective following exposure of cells to the MPTP metabolite, 1-methyl-4-phenylpyridinium (MPP+). Removal of MPTP from cultures resulted in a complete restoration of glutamate uptake after 24 h. These results show that MPTP reversibly compromises glutamate uptake in cultured astrocytes, which is dependent on the conversion of MPTP to MPP+. Such findings suggest that the glutamate transporter in astrocytes plays an important role in MPTP-induced neurotoxicity and possibly in parkinsonism.

KW - 1-Methyl-4-phenyl-l,2,3,6- tetrahydropyridine

KW - Astrocytes

KW - Glutamate transport

KW - Parkinson's disease

UR - http://www.scopus.com/inward/record.url?scp=0030911911&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030911911&partnerID=8YFLogxK

M3 - Article

VL - 68

SP - 2216

EP - 2219

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 5

ER -